Results 141 to 150 of about 18,762 (211)

Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis. [PDF]

JMIR Dermatol
Howard J, Kamili NAH, Idris H, Krueger LD.   +3 more
europepmc   +1 more source

Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS [PDF]

OBJECTIVES: Patients with chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature/proteasome-associated autoinflammatory syndrome (CANDLE/PRAAS) respond to the janus kinase inhibitor 1/2 inhibition with baricitinib at ...
Berkun, Yackov, Brogan, Paul A, de Jesus, Adriana A, Gedik, Kader Cetin, Goldbach-Mansky, Raphaela, Materne, Grace, Murias, Sara, Ortega-Villa, Ana M, Rastegar, Andre, Reinhardt, Adam, Robles, Maria, Sanchez, Gina A Montealegre, Schalm, Susanne   +12 more
core  

JAK inhibitors in livedoid vasculopathy associated with thrombophilia and refractory to anticoagulation: report and literature review. [PDF]

An Bras Dermatol
Criado GJ, Criado PR, Lorenzini D, Miot HA.   +3 more
europepmc   +1 more source

Loss of JAK inhibitor efficacy and subsequent rescue in a pediatric case of alopecia universalis. [PDF]

JAAD Case Rep
Ajmani A, Klufas T, Dhamsania IR, Yamamoto R, Zhou AE.   +4 more
europepmc   +1 more source

Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis [PDF]

OBJECTIVES: To elicit and quantify expert opinion concerning the relative merits of two treatments for a rare inflammatory disease: Juvenile dermatomyositis (JDM).
Brogan, Paul, Compeyrot-Lacassagne, Sandrine, Dehbi, Hakim-Moulay, Eleftheriou, Despina, Foley, Charlene, Green, Nathan, Leandro, Maria, Martin, Neil, McCann, Liza, Nott, Kerstin, Papadopoulou, Charalampia, Rafiq, Nadia, Varner, Giulia, Wan, Mandy, Warrier, Kishore, Whitehead, John   +15 more
core  

Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis. [PDF]

Arthritis Care Res (Hoboken)
Ramanan AV, Guly CM, Simonini G, Keller SY, Sen P, Holzkaemper T, Araújo J, Quartier P.   +7 more
europepmc   +1 more source

The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes [PDF]

Background: Alopecia, an autoimmune condition characterized by hair loss, significantly impacts millions globally, often leading to psychological distress such as anxiety and depression. Current treatments are variably effective and frequently associated
Banala, Srinidhi, Gollapudi, Abhiram, Gollapudi, Samrat, Mathew, Brian Joseph, Patel, Bhaumik, Patel, Prince   +5 more
core   +1 more source

Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort. [PDF]

Rheumatol Adv Pract
Nathan J, Farisogullari B, Jones N, Ayoub M, Brown J, Levy S, Brader J, Ersoy A, Israni B, Lloyd M, Latheef A, Hill D, Taylor A, Arachchige D, Chitsu H, Linklater H, Lather K, Gompels L, Elfar E, Malaiya R, Machado PM, Kiely PDW.   +21 more
europepmc   +1 more source

Beard hair response in alopecia areata universalis treated with baricitinib. [PDF]

JAAD Int
Trecarichi AC, Amato A, Lacarrubba F, Micali G, Dall'Oglio F.   +4 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib. [PDF]

Dermatol Ther (Heidelb)
Gwag HE, Park M, Park SY, Hong N, Heo SJ, Jung HJ, Park MY, Choi YS, Ahn J.   +8 more
europepmc   +1 more source